Essa PharmaEPIX
13F holders, Q2 2024 (June 30)31holders −2
2new positions
4sold out
2famous investors
$5.26avg. 13F price*
At the end of Q2 2024, 31 institutions reported holding Essa Pharma Inc. (EPIX) in their 13F filings, down 2 from Q1 2024. 2 opened new positions and 4 sold out. The largest holders were BVF Inc. ($46.0M), Bellevue Group AG ($41.5M) and Soleus Capital Management, L.P. ($22.1M). 2 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Essa Pharma Inc.
- CUSIP
- 29668H708
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $236K |
| Exits | 4 | $329K |
All 13F filers, Q1 2024 → Q2 2024: 675,343 shares bought and 504,010 shares sold, net +171,333 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| BVF Inc. | 1.29% | No change | 8,748,629 | $46.0M |
| Bellevue Group AG | 0.67% | No change | 7,889,583 | $41.5M |
| Soleus Capital Management, L.P. | 1.95% | Add +17.3% | 4,210,537 | $22.1M |
| Morgan Stanley | 0.00% | Reduce -0.0% | 4,177,848 | $22.0M |
| PFM Health Sciences, LP | 0.87% | Reduce -0.5% | 2,965,442 | $15.6M |
| RTW Investments, LP | 0.19% | No change | 2,298,662 | $12.1M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Reduce -6.7% | 1,474,165 | $7.8M |
| Janus Henderson Group PLC | 0.00% | Reduce -14.4% | 1,006,202 | $5.2M |
| Rhenman & Partners Asset Management AB | 0.41% | Reduce -11.6% | 806,054 | $4.2M |
| Rock Springs Capital Management LP | 0.11% | No change | 677,005 | $3.6M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -14.3% | 315,736 | $1.7M |
| Parkman Healthcare Partners LLC | 0.18% | Add +0.1% | 252,072 | $1.3M |
| Cibc World Market Inc. | 0.00% | Reduce -0.7% | 80,257 | $422K |
| D. E. Shaw & Co. | 0.00% | Reduce -2.5% | 63,481 | $334K |
| American Century Companies Inc. | 0.00% | Add +1.2% | 46,748 | $246K |
| BNP Paribas Financial Markets | 0.00% | Add +2.6% | 43,595 | $229K |
| Royal Bank of Canada | 0.00% | Add +18.0% | 36,312 | $191K |
| Kennedy Capital Management LLC | 0.00% | New | 34,465 | $181K |
| Geode Capital Management, LLC | 0.00% | No change | 26,858 | $141K |
| Citadel Advisors | 0.00% | Reduce -31.2% | 25,125 | $132K |
| Two Sigma Investments, LP | 0.00% | New | 10,313 | $54K |
| Osaic Holdings, Inc. | 0.00% | No change | 6,000 | $32K |
| BlackRock Inc. | 0.00% | No change | 5,609 | $30K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 2,500 | $13K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +4000.0% | 2,050 | $11K |
| UBS Group AG | 0.00% | Reduce -56.8% | 1,565 | $8K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 900 | $5K |
| Laurel Wealth Advisors LLC | 0.00% | No change | 600 | $3K |
| Toronto Dominion Bank | 0.00% | No change | 48 | $252 |
| JPMorgan Chase & Co. | 0.00% | No change | 21 | $110 |
| Bank of America Corp. | 0.00% | No change | 8 | $42 |
"% of holder's portfolio" is EPIX's weight in each manager's 13F, not the share of Essa Pharma Inc. the manager owns.